PTUPB, a soluble epoxide hydrolase/cyclooxygenase‑2 dual inhibitor, reduces endothelial‑to‑mesenchymal transition and improves doxorubicin‑induced vascular and cardiac toxicity. [PDF]
Dhulkifle H +6 more
europepmc +1 more source
Zinc, Soluble Epoxide Hydrolase, and the Pulmonary Vascular Paradox: Novel Insights into a Well-Known Phenomenon. [PDF]
Zhao L, Wilkins MR.
europepmc +1 more source
Distinct Single-Cell Expression Pattern of the Soluble Epoxide Hydrolase and Cytochrome p450 Epoxygenases in Human and Mouse Small Intestinal Epithelia. [PDF]
Sun L, Tang A, Liao J, Yang GY.
europepmc +1 more source
Structure-Based Design of PROTACS for the Degradation of Soluble Epoxide Hydrolase. [PDF]
Schönfeld J +30 more
europepmc +1 more source
Soluble epoxide hydrolase inhibitory constituents from the Heartwood of Toxicodendron vernicifluum: isolation, kinetic characterization, molecular modeling, and quantitative analysis. [PDF]
Kim JH +8 more
europepmc +1 more source
Allosteric Ensembles Elucidate Mechanisms of Inhibition in Human Soluble Epoxide Hydrolase
Conte M +4 more
europepmc +1 more source
Dual acting inhibitor of soluble epoxide hydrolase and Cyclooxygenase-2, attenuates glomerular injury in renal hypoplasia mice. [PDF]
Hye Khan MA +11 more
europepmc +1 more source
Novel Spiropiperidine Urea-Derived Compounds as Soluble Epoxide Hydrolase Inhibitors for Treating Diabetic Retinopathy. [PDF]
Sabnis RW.
europepmc +1 more source
Structural modification of 5-alkyl-4-phenyl-thiazole-based fatty acid amide hydrolase and soluble epoxide hydrolase inhibitors to alleviate orofacial inflammatory pain in the rat. [PDF]
Gorostiza G +11 more
europepmc +1 more source

